12.12.2022 • News
Germany’s Merck Buys Erbi Biosystems
Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The company is based in the US state of Massachusetts.
